Dr Reddy’s,India’s top pharmaceutical companies, is going to carry out the Phase III clinical trials of the Russian vaccine in India, and regulatory approvals are pending. On Wednesday the Russia’s sovereign wealth fund has aggreed that it will supply 100 million doses of its coronavirus vaccine,to Dr Reddy’s Laboratories India.


Tgese developments comes after the Russian Direct Investment Fund has signed agreements with Indian  manufacturers to produce 300 million doses of the vaccine in India, which is a major consumer of Russian oil and arms